A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomized trial.A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomized trial.
Testosterone’s estimated effect on exercise capacity was minus 0.05 versus placebo, with the range of likely values including no difference.Testosterone’s estimated effect on exercise capacity was minus 0.05 versus placebo, with the range of likely values including no difference.
At age 58, a blood fat marker threshold corresponded to 10.88% 10-year major cardiovascular event risk in men versus 4.34% in women after menopause.At age 58, a blood fat marker threshold corresponded to 10.88% 10-year major cardiovascular event risk in men versus 4.34% in women after menopause.